Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€22.40
Target price
20.11.24
€32.94
Performance (%)
203.57%
End price
21.11.24
€68.00
Summary
This prediction ended on 21.11.24 with a price of €68.00. With a performance of 203.57% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -6.250% | -6.250% | 137.410% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $36.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten